Literature DB >> 3127091

Measurement of gamma-interferon in culture supernatants of antigen-stimulated lymphocytes from patients with Schistosoma mansoni infections by a reverse passive haemagglutination assay.

A E Butterworth1, A Wilson, B A Richardson, J Harris, R K Gachuhi, D Senior, R R Coombs.   

Abstract

An assay for gamma-interferon (IFN gamma) in human lymphocyte culture supernatants, based on reverse passive haemagglutination (RPH) of red cells bearing a monoclonal anti-IFN gamma antibody, was developed and compared with a conventional virus inhibition assay. Test samples comprised supernatants of lymphocytes from patients with Schistosoma mansoni infections, cultured with or without a soluble worm antigen preparation. The two assays gave comparable results, the correlations for individual samples being good. The RPH assay was both specific and sensitive, allowing the detection of IFN gamma at 13 u/ml (1 ng/ml) or less. The advantages of the RPH assay were that it was quick, relatively inexpensive and suitable for testing large numbers of samples. In particular, between-experiment variation was very low, allowing the assay of different samples on different occasions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127091      PMCID: PMC1541446     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

1.  Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.

Authors:  S L James
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

2.  Department of Biological Sciences, University of Warwick, Coventry, CV47AL, England.

Authors:  G J Atkins; M D Johnston; L M Westmacott; D C Burke
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

3.  Direct antibody rosette-forming reactions using monoclonal markers of lymphocyte subpopulations. Methodology and applications illustrated by investigations with rat pan-T antibodies of the CAMPATH series.

Authors:  A B Wilson; J M Harris; H Waldmann; R R Coombs
Journal:  J Immunol Methods       Date:  1986-09-27       Impact factor: 2.303

Review 4.  Assays using red cell-labelled antibodies.

Authors:  R R Coombs; M L Scott; M P Cranage
Journal:  J Immunol Methods       Date:  1987-07-16       Impact factor: 2.303

Review 5.  Harnessing the red cell for immunoassays.

Authors:  R R Coombs
Journal:  Med Lab Sci       Date:  1987-01

6.  Identity between human interferon-gamma and "macrophage-activating factor" produced by human T lymphocytes.

Authors:  K W Talmadge; H Gallati; F Sinigaglia; A Walz; G Garotta
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

7.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment.

Authors:  A E Butterworth; P R Dalton; D W Dunne; M Mugambi; J H Ouma; B A Richardson; T K Siongok; R F Sturrock
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

9.  Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses.

Authors:  A E Butterworth; M Capron; J S Cordingley; P R Dalton; D W Dunne; H C Kariuki; G Kimani; D Koech; M Mugambi; J H Ouma
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.